Randomized Prospective Comparison of Bacillus Calmette-Guerin and Mitomycin-C Therapy and Prophylaxis in Superficial Transitional Cell Carcinoma of the Bladder with DNA Flow Cytometric Analysis

Value of Anti-Cancer Drugs in SWOG Phase III Clinical Trials: Evidence from Multiple Evaluation Mechanisms

V Nghiem;R Vaidya;M Banegas;D Hershman;J Unger AcademyHealth Annual Research Meeting (June 23-26, 2018, Seattle, WA), poster #B-335

Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review [Review]

AM Kamat;R Li;MA O'Donnell;PCV Black;M Roupret;JW Catto;E Comperat;MA Ingersoll;WP Witjes;DJ McConkey;JA Witjes European Urology May;73(5):738-748

PMid: PMID29055653

Association between body mass index and cancer survival in a pooled analysis of 22 clinical trials

H Greenlee;J Unger;M Leblanc;S Ramsey;D Hershman Cancer Epidemiology Biomarkers & Prevention 2017 Jan;26(1):21-29; 2016 Dec 16. [Epub ahead of print]

PMid: PMID27986655 | PMC number: PMC5370550

Comparison of survival outcomes among cancer patients treated in and out of clinical trials

J Unger;W Barlow;DP Martin;S Ramsey;M Leblanc;R Etzioni;D Hershman Journal of the National Cancer Institute 106(3):dju002; 2014 Mar 13 [Epub ahead of print];

PMid: PMID24627276 | PMC number: PMC3982777

Association between BMI at treatment initiation and cancer survival across multiple SWOG trials

H Greenlee;J Unger;M Leblanc;D Hershman AACR Research International Conference on Frontiers on Cancer Research Prevention (Sept 28-Oct 1, 2014, New Orleans, LA; poster

The prognostic sigificance of s-phase analysis in stage Ta/T1 bladder cancer: A Southwest Oncology Group study.

RW deVere White;AD Deitch;S Daneshmand;BA Blumenstein;BA Lowe;AI Sagalowsky;JA Smith;PF Schellhammer;TH Stanisic;HB Grossman;E Messing;JD Crissman;ED Crawford European Urology 37:595-600

Predictors of outcome in bladder transitional cell carcinoma (TCC) treated by intravesical chemotherapy.

R deVere White;AD Deitch;S Daneshmand;BA Blumenstein Journal of Urology 159(3)Suppl:145(#552)

Prognostic significance of DNA ploidy in Ta/T1 bladder cancer: A Southwest Oncology Group study.

RW deVere White;AD Deitch;H Tesluk;B Blumenstein;BA Lowe;AI Sagalowsky;JA Smith Jr;PF Schellhammer;TH Stanisic;HB Grossman;E Messing;JD Crissman;ED Crawford Urologic Oncology 2:27-34

Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder. A Southwest Oncology Group study.

DL Lamm;BA Blumenstein;ED Crawford;JD Crissman;BA Lowe;JA Smith Jr;MF Sarosdy;PF Schellhammer;AI Sagalowsky;EM Messing;P Loehrer;HB Grossman Urologic Oncology 1:119-126

A randomized comparison of bacillus calmette-guerin and mitomycin C prophylaxis in stage TA and T1 transitional cell carcinoma of the bladder.

DL Lamm;ED Crawford;B Blumenstein;J Crissman;R deVere White;M Wolf;B Lowe;M Sarosdy;P Schellhammer;A Sagalowsky;J Smith;HB Grossman;R Flanigan;T Moon;C Brendler;C Coltman, Jr American Urological Association 149:4(#275)